TY - JOUR
T1 - Impact of a board certification system and implementation of clinical practice guidelines for pancreatic cancer on mortality of pancreaticoduodenectomy
AU - Mizuma, Masamichi
AU - Yamamoto, Hiroyuki
AU - Miyata, Hiroaki
AU - Gotoh, Mitsukazu
AU - Unno, Michiaki
AU - Shimosegawa, Tooru
AU - Toh, Yasushi
AU - Kakeji, Yoshihiro
AU - Seto, Yasuyuki
N1 - Funding Information:
This work was supported by a grant from the Ministry of Health, Labour and Welfare of Japan (201221064A) and by a grant from Japan Society for the Promotion of Science (16K10437 and 19K09111). Acknowledgements
Funding Information:
Hiroyuki Yamamoto and Hiroaki Miyata are affiliated with the Department of Healthcare Quality Assessment at the University of Tokyo. The department is a social collaboration department supported by grants from the National Clinical Database, Johnson & Johnson K.K., and Nipro Co. Other authors have no conflicts of interest.
Funding Information:
The authors thank all of the departments and societies related to the NCD for their cooperation in this study. The authors also thank Drs. M. Mori, K. Sugihara, K. Hirata, M. Nagino, T. Ohta, H, Konno, T. Sobue, A. Nashimoto, K. Kotake, N. Kokudo, M. Yamamoto, M. Tanaka, M. Sato, H. Tokuda and Y. Kitagawa for their cooperation. This work was supported by a grant from the Ministry of Health, Labour and Welfare of the Japan (201221064A) and by a grant from Japan Society for the Promotion of Science (16K10437 and 19K09111).
Publisher Copyright:
© 2020, The Author(s).
PY - 2020/10/1
Y1 - 2020/10/1
N2 - Purposes: The aim of this study was to clarify the impact of a board certification system and the implementation of clinical practice guidelines for pancreatic cancer (PC) on the mortality of pancreaticoduodenectomy in Japan. Methods: By a web questionnaire survey via the National Clinical Database (NCD) for departments participating in the NCD, quality indicators (QIs) related to the treatment for PC, namely the board certification systems of various societies and the adherence to clinical practice guidelines for PC, were investigated between October 2014 and January 2015. A multivariable logistic regression analysis was performed to evaluate the relationship between the QIs and mortality of pancreaticoduodenectomy. Results: Of 1415 departments that registered at least 1 pancreaticoduodenectomy between 2013 and 2014 in NCD, 631 departments (44.6%), which performed pancreaticoduodenectomy for a total of 11,684 cases, answered the questionnaire. The mortality of pancreaticoduodenectomy was positively affected by the board certification systems of the Japanese Society of Gastroenterological Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery, Japanese Society of Gastroenterology, and Japanese Society of Medical Oncology as well as by institutions that used magnetic resonance imaging of ≥ 3 T for the diagnosis of PC in principle. Conclusions: The measurement of the appropriate QIs is suggested to help improve the mortality in pancreaticoduodenectomy. Masamichi Mizuma and Hiroyuki Yamamoto equally contributed.
AB - Purposes: The aim of this study was to clarify the impact of a board certification system and the implementation of clinical practice guidelines for pancreatic cancer (PC) on the mortality of pancreaticoduodenectomy in Japan. Methods: By a web questionnaire survey via the National Clinical Database (NCD) for departments participating in the NCD, quality indicators (QIs) related to the treatment for PC, namely the board certification systems of various societies and the adherence to clinical practice guidelines for PC, were investigated between October 2014 and January 2015. A multivariable logistic regression analysis was performed to evaluate the relationship between the QIs and mortality of pancreaticoduodenectomy. Results: Of 1415 departments that registered at least 1 pancreaticoduodenectomy between 2013 and 2014 in NCD, 631 departments (44.6%), which performed pancreaticoduodenectomy for a total of 11,684 cases, answered the questionnaire. The mortality of pancreaticoduodenectomy was positively affected by the board certification systems of the Japanese Society of Gastroenterological Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery, Japanese Society of Gastroenterology, and Japanese Society of Medical Oncology as well as by institutions that used magnetic resonance imaging of ≥ 3 T for the diagnosis of PC in principle. Conclusions: The measurement of the appropriate QIs is suggested to help improve the mortality in pancreaticoduodenectomy. Masamichi Mizuma and Hiroyuki Yamamoto equally contributed.
KW - Board certification
KW - Clinical practice guideline
KW - Pancreatic cancer
KW - Pancreaticoduodenectomy
KW - Quality indicator
UR - http://www.scopus.com/inward/record.url?scp=85084319156&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084319156&partnerID=8YFLogxK
U2 - 10.1007/s00595-020-02017-3
DO - 10.1007/s00595-020-02017-3
M3 - Article
C2 - 32382777
AN - SCOPUS:85084319156
SN - 0941-1291
VL - 50
SP - 1297
EP - 1307
JO - Surgery Today
JF - Surgery Today
IS - 10
ER -